Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Lupin Pharmaceuticals Inc. recalls Ganirelix Acetate Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
Products
  • Ganirelix Acetate Injection
Where it was sold

FL, MA, MI & OH

States: Florida, Massachusetts, Michigan, Ohio

Units affected
32736 vials
About this recall
Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01